Pharma Journalist 9017 posts 0 comments

Ochre Bio, an innovator in chronic liver disease drug development, announced the successful close of $30M in Series A financing. The investor syndicate included investors Khosla…
Read More...

Nanoscope Therapeutics Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, announced that the U.S. Food and Drug Administration…
Read More...

STALICLA SA, a precision neuroscience clinical stage biotech, advancing the first precision medicine platform (DEPI) for patients with Neurodevelopmental Disorders (NDDs), announced the…
Read More...

Tempus, a leader in artificial intelligence and precision medicine, today announced a new collaboration to develop a companion diagnostic (CDx) test with Kartos Therapeutics, a clinical…
Read More...

Surrozen, Inc. announced that it has entered into a collaboration and license agreement with Boehringer Ingelheim to research and develop SZN-413 for the treatment of retinal diseases.…
Read More...

Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investigation of tirzepatide for the treatment of adults with…
Read More...

Sanofi US has announced it has entered into a co-promotion service agreement with Provention Bio, Inc., for the commercialization of teplizumab in the United States. Teplizumab,…
Read More...

Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic,…
Read More...

SAE Media Group reports: The 2nd annual Transdermal and Microneedle Drug Delivery conference has been announced to take place on January 2023. After the first successful year SAE…
Read More...

SAE Media Group reports: The 15th annual Pre-Filled Syringes and Injectable Drug Devices conference will be in January 2023 with a key focus on the future of Drug Delivery and product…
Read More...